Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system

Infection and Immunity

Volumn 74, Issue 11, 2006, Pages 6118-6123

  Martinez, Luis R ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 BIS(2 METHOXY 4 NITRO 5 SULFOPHENYL) 5 [(PHENYLAMINO)CARBONYL] 2H TETRAZOLIUM HYDROXIDE; ALPHA DEFENSIN; ALPHA DEFENSIN 3; ANTIINFECTIVE AGENT; BETA DEFENSIN 1; BETA DEFENSIN 3; GLUCURONOXYLOMANNAN; MAGAININ 1; POLYPEPTIDE ANTIBIOTIC AGENT; POLYSACCHARIDE; POLYSTYRENE; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BIOFILM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; INNATE IMMUNITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHAGOCYTE; PHENOTYPE; PLANKTON; PRIORITY JOURNAL; REDUCTION;

AMINO ACID SEQUENCE; BIOFILMS; CRYPTOCOCCUS NEOFORMANS; DEFENSINS; IMMUNITY, NATURAL; MOLECULAR SEQUENCE DATA; PLANKTON; SUSPENSIONS;

EID: 33750463749     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00995-06     Document Type: Article

References (27)

1. Alspaugh, J. A., and D. L. Granger. 1991. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect. Immun. 59:2291-2296.
2. Bach, M. C., P. W. Tally, and E. W. Godofsky. 1997. Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. Neurosurgery 41:1280-1282.
3. Casadevall, A., and J. R. Perfect. 1998. Cryptococcus neoformans. ASM Press, Washington, D.C.
4. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
5. Doering, T. L., J. D. Nosanchuk, W. K. Roberts, and A. Casadevall. 1998. Melanin as a potential cryptococcal defense against microbicidal proteins. Med. Mycol. 37:175-181.
6. Gaut, J. P., G. C. Yeh, H. D. Tran, J. Byun, J. P. Henderson, G. M. Richter, M. L. Brennan, A. J. Lusis, A. Belaaouaj, R. S. Hotchkiss, and J. W. Heinecke. 2001. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci. USA 98:11961-11966.
7. Hall-Stoodley, L., J. W. Costerton, and P. Stoodley. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
8. Jesaitis, A. J., M. J. Franklin, D. Berglund, M. Sasaki, C. I. Lord, J. B. Bleazard, J. E. Duffy, H. Beyenal, and Z. Lewandowski. 2003. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J. Immunol. 171:4329-4339.
9. Klebanoff, S. J. 1980. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93:480-489.
10. Lehrer, R. I., and T. Ganz. 1996. Endogenous vertebrate antibiotics: defensins, protegrins, and other cysteine-rick antimicrobial peptides. Ann. N. Y. Acad. Sci. 797:228-239.
11. Leid, J. G., M. E. Shirtliff, J. W. Costerton, and A. P. Stoodley. 2002. Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms. Infect. Immun. 70:6339-6345.
12. Mansour, M. K., L. E. Yauch, J. B. Rottman, and S. M. Levitz. 2004. Protective efficacy of antigenic fractions in mouse models of cryptococcosis. Infect. Immun. 72:1746-1754.
13. Martinez, L. R., and A. Casadevall. 2005. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect. Immun. 73:6350-6362.
14. Martinez, L. R., and A. Casadevall. 2006. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 50:1021-1033.
15. Martinez, L. R. 2006. Biofilm formation by Cryptococcus neoformans: effect of specific antibody and consequences for drug therapy and immune responses. Ph.D. thesis. Albert Einstein College of Medicine of Yeshiva University, Bronx, New York.
16. Meshulam, T., S. M. Levitz, L. Christin, and R. D. Diamond. 1995. A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanilide (XTT). J. Infect. Dis. 172:1153-1156.
17. Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97:8841-8848.
18. Nosanchuk, J. D., and A. Casadevall. 1997. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect. Immun. 65:1836-1841.
19. Polacheck, I., Y. Platt, and J. Aronovitch. 1990. Catecholamines and virulence of Cryptococcus neoformans. Infect. Immun. 58:2919-2922.
20. Ramage, G., S. P. Saville, D. P. Thomas, and J. L. Lopez-Ribot. 2005. Candida biofilms: an update. Eukaryot. Cell 4:633-638.
21. Selsted, M. E., and A. J. Ouellette. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551-557.
22. Singh, P. K., M. R. Parsek, E. P. Greenberg, and M. J. Welsh. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417:552-555.
23. Steenbergen, J. N., H. A. Shuman, and A. Casadevall. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. USA 98:15245-15250.
24. Theraud, M. B., Y. Guiguen, C., and J.-P. Gangneux. 2004. Efficacy of antiseptics and disinfectants on clinical and environmental yeast isolates in planktonic and biofilm conditions. J. Med. Microbiol. 53:1013-1018.
25. Vecchiarelli, A. 2000. Immunoregulation by capsular components of Cryptococcus neoformans. Med. Mycol. 38:407-417.
26. Walker, T. S., K. L. Tomlin, G. S. Worthen, K. R. Poch, J. G. Lieber, M. T. Saavedra, M. B. Fessler, K. C. Malcolm, M. L. Vasil, and J. A. Nick. 2005. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 73:3693-3701.
27. Walsh, T. J., R. Schlegel, M. M. Moody, J. W. Costerton, and M. Salcman. 1986. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 18:373-375.